At a glance
ClinicalIndex Comparison RecordN/ACompleted· 104 enrolled
Drug / intervention
SN60AT +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Posterior Capsule Opacification (PCO) Evaluation of the AcrySof SN60AT Lens vs. SN60WF Lens
In Brief
A clinical study evaluating SN60AT and SN60WF for Cataract. Completed, enrolled 104 participants across 1 site.
Detailed Summary
To assess posterior capsule opacification (PCO) in patients implanted with either the AcrySof SN60AT lens or the AcrySof SN60WF lens.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartDec 2006
First PostedSep 2008
Primary CompletionAug 2009
TodayJul 2026
First PostedSep 30, 2008
Enrollment StartDec 1, 2006
Primary CompletionAug 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 17.8 years ago
Interventions
SN60ATdevice
Implantation with the AcrySof Intraocular Lens Model SN60AT following cataract removal.
SN60WFdevice
Implantation with the AcrySof Intraocular Lens Model SN60WF following cataract removal.